Popular Trials
Monoclonal Antibodies
Rituximab for Gout
This trial is testing the safety and feasibility of treating a group of people with a type of gout that is difficult to control. These individuals have not responded well to oral medications and have lost their response
Popular Filters
Trials With No Placebo
Xanthine Oxidase Inhibitor
Treat-to-Target vs Symptom Management for Gout
"This trial is comparing two different treatments for gout to see which one is better for patients in terms of gout symptoms and other related health issues like heart, metabolism, and kidney problems."
Frequently Asked Questions
Introduction to gout
What are the top hospitals conducting gout research?
Gout, a form of arthritis that affects millions worldwide, is receiving dedicated attention from various hospitals conducting clinical trials. In Birmingham, Alabama, the University of Alabama at Birmingham leads the way with four ongoing gout trials and a commendable history of eleven completed studies since their first recorded trial in 2008. MD Medical Research in Oxon Hill has also made significant contributions to this field with three active gout trials and four previous investigations after initiating their inaugural trial in 2019.
Meanwhile, Velocity Clinical Research located in West Jordan, Salt Lake City is actively engaged in three current gout trials while having conducted three past studies as well; they started exploring potential treatments for this condition only recently in 2020. The Altoona Center for Clinical Research situated in Duncansville holds an impressive record of eighteen all-time gout trials even though they are currently carrying out just three. Their pioneering investigation into finding innovative solutions for patients suffering from gout began back in 2006.
Lastly but certainly not least, Syed Research Consultants LLC based out of Muscle Shoals joins the ranks by contributing two active clinical trials focused on tackling this debilitating condition. Although they have only been involved since 2022, every effort counts when it comes to advancing our understanding and treatment options for gout sufferers.
These hospitals represent beacons of hope within the medical community as researchers tirelessly work towards alleviating pain and improving quality of life for individuals afflicted by gout. Through these collaborative efforts across different locations and institutions, we move closer to unlocking breakthroughs that can potentially change lives around the world affected by this common yet often overlooked form of arthritis.
Which are the best cities for gout clinical trials?
When it comes to gout clinical trials, several cities have emerged as leaders in research and development. Tampa, Florida leads the pack with 8 active trials exploring treatments like Tigulixostat 100mg, Allopurinol Tablet, Pegloticase with Methotrexate (MTX), and others. Miami, Florida closely follows with 7 ongoing studies focused on innovative approaches such as Tigulixostat 100mg, SAP001 10 mg, Pegloticase with MTX, and more. Birmingham, Alabama also has a significant presence in gout clinical trials with 7 active studies investigating treatments like Tigulixostat 100mg and Cohort A among others. These cities provide individuals suffering from gout access to cutting-edge clinical trials that may lead to improved management of this condition.
Which are the top treatments for gout being explored in clinical trials?
Exciting research is underway to find effective treatments for gout, a painful inflammatory condition. Leading the way in clinical trials are two promising options: dapansutrile and phone-based Walk With Ease. Dapansutrile, listed for the first time in 2023, is currently being tested in one active trial dedicated to gout. Likewise, phone-based Walk With Ease shows promise with its own active trial focused on this debilitating condition since its introduction in 2022. These innovative approaches offer hope for improved management and relief from gout symptoms.
What are the most recent clinical trials for gout?
Recent clinical trials are providing hope for individuals suffering from gout, a painful and debilitating condition. One trial, Cohort A, is currently in Phase 2 and became available on 4/17/2023. Additionally, Tigulixostat 100mg has shown promise in its Phase 3 trial that became available on 3/30/2023. Another noteworthy study involves Dapansutrile in both Phase 2 and Phase 3 stages since becoming available on 1/6/2023. These trials signify significant progress in the search for effective treatments to alleviate the symptoms of gout and improve patients' quality of life.
What gout clinical trials were recently completed?
Several recent clinical trials have made significant strides in the field of gout treatment. In November 2021, Arthrosi Therapeutics completed a trial investigating the effectiveness of AR882 Dose 2. This was followed by LG Chem's completion of a trial for LC350189 200mg in September 2021. Allena Pharmaceuticals also achieved an important milestone with their study on ALLN-346, which concluded in July 2021. Lastly, Horizon Therapeutics Ireland DAC successfully wrapped up their clinical trial focusing on Pegloticase in March 2021. These advancements highlight the ongoing efforts to develop innovative therapies and enhance outcomes for individuals living with gout.